Hers review
Every medication price here is missing $149, and Hers states plainly that the membership behind it is not optional.
The verdict
Hers prices compounded semaglutide at $199 by injection and $149 as an oral, with compounded tirzepatide at $299 and oral orforglipron at $149, all read August 2026 — and none of those figures is what a buyer pays. A Hers Weight Loss Membership is required alongside them at $39 for the first month and $149 a month afterwards, and the company states in its own words that medication is not available without one.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Orforglipron · Semaglutide · Tirzepatide
- Form
- Injection · Oral
- States
- 50
- Injection
- From $348/mo
- Oral
- From $298/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Availability
- 50 states
Hers is the women's arm of a large consumer telehealth brand, and it carries an unusually wide GLP-1 catalog: two compounded molecules across injection and oral forms, plus oral orforglipron, which very few sellers price at all. What it sells alongside all of them is a membership, and that membership is the part that decides what the service actually costs.
Who writes the prescription, and what do they see?
The membership is how a reader reaches a prescriber at all, so the clinical relationship and the recurring charge are the same thing here rather than two separable purchases. Hers is clear about that arrangement. The sentence about medication being unavailable without a membership is on its own pages, not inferred from a footnote, which puts it ahead of the sellers that let a reader discover a standing fee at checkout.
What a buyer is really choosing is a subscription with a pharmacy attached, and the first month is priced to make that easy to start: $39 rather than $149, which softens the largest recurring charge exactly once. From month two the membership costs more than three of the four medication lines it unlocks, which is an unusual shape for a service to have and the single most important thing to understand before enrolling.
What happens when the dose goes up?
Hers does not publish what happens to a medication figure as the dose climbs, and on the compounded lines that leaves the larger question open. The membership at least does not move: $149 a month is stated flatly, so a buyer escalating through a titration schedule knows one of the two components will hold even if the other does not.
What the price includes
The arithmetic is the review. Oral semaglutide at $149 becomes $298 a month once the membership is counted, and the injection at $199 becomes $348. Tirzepatide at $299 becomes $448. Six months on the oral line is therefore $1,788 rather than $894, and a reader comparing the medication figure against a seller that quotes an all-in rate is comparing half a price against a whole one. The orforglipron line, flagged as new on the page, carries the same $149 membership on top of its own $149.
What it claims, and what it cites
The semaglutide and tirzepatide lines are compounded preparations, which means they are not FDA-approved and the agency does not review them for safety or quality before they are dispensed. The orforglipron line is a newer molecule and its presence here is notable in itself, since a published price for it is rare anywhere.
Where it holds up, and where it does not
- Strength: The requirement is written in the seller's own words
- Strength: Orforglipron priced, which is rare
- Strength: Membership rate holds at $149 monthly
- Strength: Coverage stated across 50 states
- Limitation: No medication figure is the real cost
- Limitation: Membership exceeds three of four drug prices
- Limitation: The $39 first month applies once
- Limitation: Dose behavior is not published
What the evidence says about this kind of treatment
The assessment above is about Hers. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who wants a large brand and a wide catalog, and who will budget the membership as the main charge.
- Wrong for
- A reader comparing medication prices across sellers without adding a required fee to each.
How Hers compares
| Seller | Who it suits | Go |
|---|---|---|
| Readers who will prepay a year and want coaching and membership inside one figure | See Found → | |
| NextMeds | A reader who wants one charge covering medication and care, and who treats a rate running under a countdown timer as an intro rather than a standing price. | See NextMeds → |
| Collective | A reader who will stay on treatment for a full twelve months, which is the term the annual membership is priced against. | See Collective → |
More GLP-1 telehealth sellers reviews: Bon HealthBrello HealthCandor RxCeliaRxCitizen MedsClume Health
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- What does Hers actually cost a month?
- The medication figure plus $149. Oral semaglutide at $149 becomes $298, the injection at $199 becomes $348, and tirzepatide at $299 becomes $448, read August 2026.
- Can the membership be skipped?
- No. Hers states on its own pages that medication is not available without a membership, which is why every figure here is quoted as a component rather than a price.
- Is the $39 first month a discount on the medication?
- No, it applies to the membership and only once. From the second month the membership charge is $149 alongside whatever the medication costs.
- Why does orforglipron matter here?
- It is a newer GLP-1 and very few sellers publish a figure for it at all. Hers lists it as an oral at $149, with the same membership required on top.
- Is Hers legit?
- Hers is a GLP-1 telehealth sellers service. Its stated availability: 50 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is Hers expensive compared with other GLP-1 telehealth sellers?
- Hers publishes a starting figure of $298/mo. Across the 83 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $299 with a median of $179, which puts Hers above the median. The other 5 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.